Picture of Torrent Pharmaceuticals logo

TORNTPHARM — Torrent Pharmaceuticals News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Torrent Pharma climbs on strong quarterly results

** Shares of Torrent Pharma TORP.NS climb 2.1% to 3,697.8 rupees

** Drugmaker's Q1 consol net profit rose 20% y/y on strong demand for drugs used to treat long-term conditions

** At least 10 brokerages increased PTs after results, raising median PT to 3,800 rupees from 3,580 rupees last month, as per data compiled by LSEG

** HSBC says continued traction in TORP's India and Brazil segments, a pick-up in sales in the U.S. to support a healthy EBITDA margin outlook

** Adds, co expects EBITDA margins of at least 32.9% for the remaining quarters of FY26; its operating EBITDA margins stood at 32.5% in Q1

** Jefferies expects TORP's India, Brazil sales to continue outperforming, while losses in U.S. likely to reduce through fiscal year

** TORP up ~8% YTD, as of Monday's close

(Reporting by Manvi Pant in Bengaluru)

((Manvi.Pant@thomsonreuters.com; +918447554364;))

Recent news on Torrent Pharmaceuticals

See all news